BridgeMD
Compares treatment options for Inguinal Hernia
Official title Conventional Versus Robot Assisted Laparoscopic Inguinal Hernia Repair
ClinicalTrials.gov ID: NCT03904888
What this study is testing
- What it's testing
- Evaluate the early postoperative course of patients undergoing laparoscopic inguinal hernia repair with either a conventional or a robot assisted approach and with or without the injection of the trocar wounds with a local anesthetic.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- adult patients presenting with a bilateral inguinal hernia planned for a minimal invasive laparoscopic repair
You likely can't join if
- Age below 18 years
- unilateral groin hernia repair
- incarcerated hernias
- open hernia repair
- no informed consent
- pregnant women
See the full eligibility criteria
- adult patients presenting with a bilateral inguinal hernia planned for a minimal invasive laparoscopic repair
- Age below 18 years
- unilateral groin hernia repair
- incarcerated hernias
- open hernia repair
- no informed consent
- pregnant women
- ASA score 4 or more
- patient included in another study.
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.